As the situation with COVID-19 continues to evolve, our top priority during these challenging times continues to be health and safety.

To provide clarity to investigators and coordinators currently working on studies, AHS has provided a guidance memo which can be viewed by clicking the link below:
AHS COVID-19 Research Guidance Memo

AHS is also directing researchers to the following Cross Cancer Institute FAQ document: 

CCI COVID-19 FAQ for Sponsors
Our communities are working hard to prevent the spread of COVID-19, and to support these efforts, we have enacted our business resumption plan with our staff working from home to support social distancing efforts.

NACTRC is committed to supporting the research community in the best possible way and remain “business-as-usual” during this challenging time.


Dr. Lawrence Richer, Centre Director
Simon Wong, Director of Operations
Scott Jamieson, Director of Clinical Operations

More News